
Sign up to save your podcasts
Or
Amy West, Head of US Digital Health & Innovation Strategy at Novo Nordisk, joined the show in April 2023 during the early days of the semaglutide rush to share how human-centered clinical approaches are innovating digital therapeutics and patient treatments.
What do you think?
This show is produced by the Consumer-First Health Group, the community for consumer health enthusiasts. (#393)
See omnystudio.com/listener for privacy information.
4.6
1616 ratings
Amy West, Head of US Digital Health & Innovation Strategy at Novo Nordisk, joined the show in April 2023 during the early days of the semaglutide rush to share how human-centered clinical approaches are innovating digital therapeutics and patient treatments.
What do you think?
This show is produced by the Consumer-First Health Group, the community for consumer health enthusiasts. (#393)
See omnystudio.com/listener for privacy information.
9,538 Listeners
112,398 Listeners
256 Listeners
56,438 Listeners
9,616 Listeners
9,633 Listeners
58,104 Listeners
100 Listeners
29,378 Listeners
16,007 Listeners
4,456 Listeners
156 Listeners
10 Listeners
1,294 Listeners
9,272 Listeners